Species
|
Resource
|
RRC ID
|
Title
|
Journal
|
Published
|
Link
|
DNA material
|
CSII-CMV-MCS-IRES2-Bsd (RDB04385)
,
pCMV-VSV-G-RSV-Rev (RDB04393)
,
pCAG-HIVgp (REB04394)
|
81311
|
CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP.
|
Life Sci Alliance |
2021-9-1 |
Pubmed
Full text
|
Human and Animal Cells
|
YSCCC(RCB1549)
,
HuCCT1(RCB1960)
,
RBE(RCB1292)
,
SSP-25(RCB1292)
|
79367
|
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.
|
Gastroenterology |
2012-4-1 |
Pubmed
Full text
|
Human and Animal Cells
|
RBE(RCB1292)
|
79009
|
EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion-Positive Cholangiocarcinoma.
|
Cancer Discov |
2022-5-2 |
Pubmed
Full text
|
Human and Animal Cells
|
CACO-2(RCB0988)
,
COLO205(RCB2127)
|
78173
|
p53-armed oncolytic adenovirus induces autophagy and apoptosis in KRAS and BRAF-mutant colorectal cancer cells.
|
PLoS One |
2023-1-1 |
Pubmed
Full text
|
Human and Animal Cells
|
MCF7(RCB1904)
|
77423
|
Suppression of heregulin β signaling by the single N-glycan deletion mutant of soluble ErbB3 protein.
|
J Biol Chem |
2013-11-15 |
Pubmed
Full text
|
Human and Animal Cells
|
PC-14(RCB0446)
|
77330
|
High-fat diet induces C-reactive protein secretion, promoting lung adenocarcinoma via immune microenvironment modulation.
|
Dis Model Mech |
2023-11-1 |
Pubmed
Full text
|
C.elegans
|
tm810
|
76147
|
Discovery of nonautonomous modulators of activated Ras.
|
G3 (Bethesda) |
2022-9-30 |
Pubmed
Full text
|
Drosophila
|
1395R-1
,
4217R-2
|
74696
|
EGFR signaling activates intestinal stem cells by promoting mitochondrial biogenesis and β-oxidation.
|
Curr Biol |
2022-9-12 |
Pubmed
Full text
|
Drosophila
|
DGRC#104055
|
74500
|
Sas-Ptp10D shapes germ-line stem cell niche by facilitating JNK-mediated apoptosis.
|
PLoS Genet |
2023-3-1 |
Pubmed
Full text
|
Human and Animal Cells
|
PC-9(RCB4455)
|
74431
|
Inhibition of EGFR and MEK surmounts entrectinib resistance in a brain metastasis model of NTRK1-rearranged tumor cells.
|
Cancer Sci |
2022-7-1 |
Pubmed
Full text
|
Human and Animal Cells
|
PC-9(RCB4455)
|
73998
|
Osimertinib-tolerant lung cancer cells are susceptible to ferroptosis.
|
Biochem Biophys Res Commun |
2023-1-22 |
Pubmed
Full text
|
Human and Animal Cells
|
II-18(RCB2093)
|
73644
|
Mutant forms of EGFR promote HER2 trafficking through efficient formation of HER2-EGFR heterodimers.
|
Lung Cancer |
2023-1-1 |
Pubmed
Full text
|
Human and Animal Cells
|
PC-9(RCB4455)
,
Jurkat(RCB3052)
|
73099
|
A fluorogenic probe for predicting treatment response in non-small cell lung cancer with EGFR-activating mutations.
|
Nat Commun |
2022-11-14 |
Pubmed
Full text
|
Drosophila
|
|
70846
|
EGFRAP encodes a new negative regulator of the EGFR acting in both normal and oncogenic EGFR/Ras-driven tissue morphogenesis.
|
PLoS Genet |
2021-8-1 |
Pubmed
Full text
|
Human and Animal Cells
|
TE-1(RCB1894)
,
TE-9(RCB1988)
,
TE-11(RCB2100)
|
69813
|
Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling.
|
Proc Natl Acad Sci U S A |
2013-3-12 |
Pubmed
Full text
|
Human and Animal Cells
|
HSC-2(RCB1945)
,
HSC-3(RCB1975)
,
HSC-4(RCB1902)
,
SAS(RCB1974)
|
69742
|
Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell-derived exosome uptake by oral squamous cell carcinoma through macropinocytosis.
|
Cancer Sci |
2022-2-1 |
Pubmed
Full text
|
Human and Animal Cells
|
PC-9(RCB4455)
|
68844
|
Design, synthesis and evaluation of the osimertinib analogue (C-005) as potent EGFR inhibitor against NSCLC.
|
Bioorg Med Chem |
2018-12-15 |
Pubmed
Full text
|
Human and Animal Cells
|
PC-9(RCB4455)
|
68842
|
Trametinib overcomes KRAS-G12V-induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR-mutant lung cancer.
|
Cancer Sci |
2021-9-1 |
Pubmed
Full text
|
Human and Animal Cells
|
PC-9(RCB4455)
|
68841
|
Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer.
|
Nat Commun |
2021-6-17 |
Pubmed
Full text
|
Human and Animal Cells
|
PC-9(RCB4455)
|
68838
|
EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of Osimertinib on Cell Cycle Progression in Non-Small Cell Lung Cancer.
|
Int J Mol Sci |
2021-8-7 |
Pubmed
Full text
|